U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819370) titled 'Enamel Lesion Detection With New DX Tool' on Sept. 02.
Brief Summary: The primary objective of this 12-week study is to test BlueCheck's ability to identify enamel lesions consistently, and its ability to track changes in these lesions over time.
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Enamel Lesions
Caries
Intervention:
DEVICE: BlueCheck
BlueCheck, a carious lesion detection formulated device, will be used to track enamel lesions for patients who are newly receiving a high fluoride toothpaste.
DRUG: Prevident 5000ppm Booster Plus Toothpaste
This clinical study is testing the ability of BlueCheck t...